Skip to content

Study on the effectiveness of supplementing omega-3 fatty acids before IVF/ICSI in patients with infertility complicated with hyperlipidemia

Study on the effectiveness of supplementing omega-3 fatty acids before IVF/ICSI in patients with infertility complicated with hyperlipidemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103319
Enrollment
Unknown
Registered
2025-05-27
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility complicated with hyperlipidemia

Interventions

?-3 fatty acid intervention group:Provide pre-pregnancy diet and exercise guidance for this group of patients: This includes cooking with less oil, controlling sugar with less salt, appropriately incr
Blank control group:Only pre-pregnancy dietary and exercise guidance was provided, without supplementation of omega-3 fatty acid preparations.

Sponsors

Guangzhou Medical University Affiliated Qingyuan Hospital (Qingyuan People's Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Infertile patients aged 20-38 years with combined hyperlipidemia and undergoing IVF/ICSI-ET assisted pregnancy; 2) 18 kg/m ² = Body mass index (BMI) 1.1 ng/ml, AFC on both ovaries > 5-7, basal FSH < 10 IU/L; 5) Voluntarily and agreed to participate in this study.

Exclusion criteria

Exclusion criteria: 1) Clearly identify diseases that affect the structure and function of the uterus, such as uterine malformations, submucosal fibroids, intramural fibroids that affect the shape of the uterine cavity, and severe adenomyosis of the uterus; History of endometrial tuberculosis, abnormal endometrial hyperplasia lesions, intrauterine adhesions. 2) Stage III-IV endometriosis, preconception diabetes, and untreated thyroid dysfunction. 3) Untreated hydrosalpinx; 4) Chromosomal abnormalities of either spouse; 5) Recurrent miscarriage and repeated implantation failure; 6) Have a habit of smoking and drinking.

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy rate;

Secondary

MeasureTime frame
The number of mature eggs (MII);Rate of high-quality embryos;Number of retrieved oocytes;Normal fertilization (2PN) rate;The changes in blood lipid levels before pregnancy and between the start date of ovulation induction;Abortion rate;The incidence of moderate to severe OHSS (late-onset);

Countries

China

Contacts

Public ContactCairong Chen

Guangzhou Medical University Affiliated Qingyuan Hospital (Qingyuan People's Hospital)

cairong1222@163.com+86 139 2768 1331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026